David Allard

SEP 5, 2026 · JOURNAL ARTICLE

PRMT7 restricts CD8+ T cells expansion via the NF-ΚB pathway

Nature Communications

A mechanistically sound study combining genetic and pharmacological approaches in mouse and human models, demonstrating PRMT7 inhibition enhances CD8+ T cell function, but limited by single tumor model and lack of phase-controlled clinical trial.